Lumentum insider plans sale of 4,000 shares

Lumentum Holdings Inc. insider plans stock sale.

Rhea-AI Filing Summary

Lumentum Holdings Inc. insider plans stock sale. A Form 144 notice reports a planned sale of 4,000 shares of Lumentum common stock through UBS Financial Services Inc. on or about 02/12/2026 on Nasdaq, with an aggregate market value of $2,389,974.75.

The shares to be sold were acquired via RSU vestings from Lumentum Holdings Inc. on 11/09/2019 (1,562 shares) and 11/14/2020 (2,438 shares), both paid in cash. The filing also notes a prior sale of 4,849 common shares on 02/06/2026 for gross proceeds of $2,596,536 by Penelope Herscher.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Lumentum Holdings (LITE) disclose?

The Form 144 discloses a planned sale of 4,000 Lumentum common shares. The sale is to be executed through UBS Financial Services Inc. on Nasdaq, providing notice of a potential insider disposal under Rule 144 requirements.

How many Lumentum (LITE) shares are proposed to be sold under this Form 144?

The filing shows a proposed sale of 4,000 Lumentum common shares. These shares have an aggregate market value of $2,389,974.75, and are planned to be sold on or about February 12, 2026, through UBS Financial Services Inc.

What is the aggregate market value of the Lumentum (LITE) shares in this Form 144?

The planned 4,000-share sale has an aggregate market value of $2,389,974.75. This valuation reflects the market price used in the Form 144 notice and helps indicate the approximate dollar size of the proposed transaction.

How were the Lumentum (LITE) shares in this Form 144 originally acquired?

The shares were acquired through RSU vesting from Lumentum Holdings Inc. One RSU vesting occurred on November 9, 2019 for 1,562 shares, and another on November 14, 2020 for 2,438 shares, with both transactions paid in cash.

What prior Lumentum (LITE) stock sales are reported in the last three months?

The filing reports that Penelope Herscher sold 4,849 Lumentum common shares on February 6, 2026. These shares generated gross proceeds of $2,596,536, and this prior activity is disclosed as required for the last three months.

Which broker and exchange are involved in the Lumentum (LITE) Form 144 sale?

The planned sale will be executed through UBS Financial Services Inc., located in Weehawken, New Jersey. The Form 144 specifies that the Lumentum common shares are expected to be sold on the Nasdaq stock market.

Who is the selling security holder in the Lumentum (LITE) Form 144 filing?

The filing identifies Penelope Herscher as the person for whose account the Lumentum shares are to be sold. Her address is listed as 1001 Ridder Park Drive, San Jose, California, consistent with Rule 144 disclosure requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 04:59 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001232019
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Lumentum Holdings Inc
SEC File Number	001-36861
Address of Issuer	1001 Ridder Park Dr San Jose CALIFORNIA 95131
Phone	4085465483
Name of Person for Whose Account the Securities are To Be Sold	Penelope Herscher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	4000	2389974.75	71400000	02/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2020	RSU vesting	Lumentum Holdings Inc			2438	11/14/2020	Cash
Common	11/09/2019	RSU Vesting	Lumentum Holdings Inc			1562	11/09/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Penelope Herscher 1001 Ridder park Dr San Jose CA 95131	Common	02/06/2026	4849	2596536

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Penelope Herscher
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)